Antikörper-Formulierungen

Patent europeic · EP2889310 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2889310
Numer da la dumonda
EP15155712
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
03-07-2008
Publitgà
01-07-2015
Concedì
20-12-2017
La protecziun finescha il pli tard
02-07-2028
Proxima taxa annuala scadenta
31-07-2027
Classas IPC
C07K 16/00 (2006.01)
A61K 39/395 (2006.01)
C07K 16/28 (2006.01)
A61K 9/00 (2006.01)
Prioritad
US 948220 P 06.07.2007
Derivà da
EP08781323
Lingua da l’annunzia
englais
Funtauna
Swissreg

Certificats cumplementars da protecziun

In certificat prolunghescha la protecziun dal patent per in medicament u in product da protecziun da plantas admess en Svizra.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-08-2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. 01-08-2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. 01-08-2024

    Midada

    Published in Swissreg on 01.08.2024

  4. 01-08-2023

    Midada

    Published in Swissreg on 01.08.2023

  5. 01-08-2022

    Midada

    Published in Swissreg on 01.08.2022

  6. 20-12-2017

    Concedì

    Published in Swissreg on 20.12.2017

Partidas

Inventur

Brisbane, Charlene E

King of Prussia, PA 19406, US

Ketkar, Amol Sharad

King of Prussia, PA 19406, US

Lashmar, Ulla Tove

Brentford Middlesex TW8 9GS, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.